Abdullah Haj-Yehia
Overview
Explore the profile of Abdullah Haj-Yehia including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
135
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Haj-Yehia A, Nassar T, Kadery B, Lotan C, Daas N, Kleinman Y
Exp Clin Cardiol
. 2009 Aug;
7(2-3):85-92.
PMID: 19649229
Objective: To evaluate the effects of 3-carbamoyl-PROXYL (CP), a stable superoxide dismutase (SOD) mimic compound, on oxidative stress markers and endothelial dysfunction in diabetic rats. Animals And Methods: Rats were...
2.
Nassar T, Akkawi S, Shina A, Haj-Yehia A, Bdeir K, Tarshis M, et al.
Blood
. 2003 Sep;
103(3):897-902.
PMID: 14512309
Tissue type plasminogen activator (tPA) is a key enzyme in the fibrinolytic cascade. In this paper we report that tPA contains 2 independent epitopes that exert opposite effects on blood...
3.
Nassar T, Akkawi S, Bar-Shavit R, Haj-Yehia A, Bdeir K, Al-Mehdi A, et al.
Blood
. 2002 Oct;
100(12):4026-32.
PMID: 12393692
We have previously identified alpha-defensin in association with medial smooth muscle cells (SMCs) in human coronary arteries. In the present paper we report that alpha-defensin, at concentrations below those found...
4.
Nassar T, Haj-Yehia A, Akkawi S, Kuo A, Bdeir K, Mazar A, et al.
J Biol Chem
. 2002 Aug;
277(43):40499-504.
PMID: 12171938
Urokinase plasminogen activator (uPA) is a multifunctional protein that has been implicated in several physiological and pathological processes involving cell adhesion and migration in addition to fibrinolysis. In a previous...
5.
Nassar T, Kadery B, Lotan C, Daas N, Kleinman Y, Haj-Yehia A
Eur J Pharmacol
. 2002 Feb;
436(1-2):111-8.
PMID: 11834254
Evidence exists to support the beneficial effects of superoxide dismutase on endothelial dysfunction induced by hyperglycemia in vitro. In vivo, however, studies of the effects of native superoxide dismutase preparations...